Unichem Laboratories has received tentative approval for ANDA of Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration (USFDA) for a generic version of Januvia (sitagliptin) tablets, 25 mg, 50 mg, and 100 mg, of Merck Sharpe and Dohme Corp (Merck).
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The product will be commercialised from Unichem’s Goa Plant on receipt of full approval.
Discover the 8 key signs of poor digestive health that could be affecting your overall…
Cervical Cancer Treatment: In this video we will discuss about new and successful treatments for…
Discover the transformative power of a daily 40-minute walk and its incredible health benefits for…
Iodine Deficiency: Did you know that iodine deficiency can lead to obesity and weakness? In…
Discover the top five foods that can elevate your blood pressure and contribute to hypertension.…
Cancer Causing Elements in Beauty Products: Use of chemicals in beauty products can have negative…